Draft amendments to the New Drugs and Clinical Trials Rules, 2019, and the Drugs Rules, 1945, would require manufacturers of antimicrobials to obtain Central Licensing Authority permission before applying for a State licence, amid concerns over antimicrobial resistance, and introduce separate forms for the wholesale sale of bulk drugs.